- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07680491
Non-surgical Treatment of Peri-implant Pockets With H42 (H42)
This prospective, observational study evaluates the efficacy and safety of H42 non-surgical treatment for peri-implant pockets. The trial involves 56 patients, with 28 subjects receiving the H42 treatment and 28 acting as a control group to monitor soft tissue healing and bone level changes.
Clinical outcomes focus on Pocket Probing Depth (PPD) and Silness and Löe Plaque Index (PI) measured at baseline, 1 month, and 3 months. Gingival inflammation, pain intensity on a 0-10 NRS scale, and absence of infection are monitored at baseline, 7, 14, and 21 days, and at 1 and 3 months. Additionally, a five-point tissue assessment evaluates color, suppuration, granulation tissue, bleeding, and incision margins. Radiographic analysis at baseline and 3 months uses standardized periapical x-rays to measure bone level, intra-bony defect height, width, and angulation. Safety is assessed through the continuous registration of adverse events.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Marco Morroni, PhD
- Telefonnummer: +39 389 059 0480
- E-mail: m.morroni@bioteck.com
Undersøgelse Kontakt Backup
- Navn: Anna Di Bona, PhD
- Telefonnummer: +39 32779983709
- E-mail: a.dibona@bioteck.com
Studiesteder
-
-
-
Seville, Spanien, 41009
- Rekruttering
- Faculty of Dentistry, University of Seville
-
Kontakt:
- Guillermo Machuca-Portillo, MD
- Telefonnummer: +34 954481128
- E-mail: gmachuca@us.es
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Men or women with age ≥ 25 and ≤ 65 years.
- Subjects affected by peri-implant pockets with probing depth (PD) in the range between 6 to 8 mm.
- Each subject can have from 1 to 5 defects.
- Subjects willing to provide signed informed consent to clinical investigation participation.
Exclusion Criteria:
- Use of aspirin and antiplatelet agents a week before treatment.
- Subjects smokers ≥ 10 cigarettes per day.
- Subjects presenting current or previous bleeding disorders.
- Subjects taking or having indications for anticoagulant therapy.
- Concomitant treatments or procedures to improve gum health over the last six months before the clinical investigation enrolment, such as HA gel treatments, injection of fillers, and surgery.
- Subjects suffering from infectious diseases, including herpes simplex infection, active hepatitis, or human immunodeficiency virus.
- Subjects with dental aesthetic surgery in the preceding 12 months before the clinical investigation enrolment.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
|---|
|
H42 treated group
28 patients treated with ultrasonic treatment and manual curettes + H42®
|
|
Control group
28 patients only with ultrasonic treatment and manual curettes
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pocket Probing Depth (PPD)
Tidsramme: At 1 month and 3 months in comparison with the baseline value
|
The distance measured from the base of the pocket to the most apical point on the gingival margin, and it will be measured with an electronic Florida probe at controlled pressure
|
At 1 month and 3 months in comparison with the baseline value
|
|
Plaque Index (PI)
Tidsramme: At 1 month and 3 months in comparison with the baseline
|
For each tooth, the four-point scale Silness and Löe Plaque Index is used (Score 0: Excellent; 3: poor)
|
At 1 month and 3 months in comparison with the baseline
|
|
Degree of inflammation
Tidsramme: Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
Not inflamed, mild inflamed, Moderately inflamed, Very inflamed
|
Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
|
NRS scale
Tidsramme: Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
Numeric Rating Scale is a simple, reliable tool used to measure pain intensity on a scale from 0 to 10 (0: no pain; 10: maximum pain)
|
Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
|
Absence of infection
Tidsramme: Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
Clinical evaluation to assess the absence of infection, specifically defined as the absence of suppuration (pus formation), at the treated site as evaluated by the Investigator.
|
Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Tissue assessment
Tidsramme: Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
Color, suppuration, granulation tissue, bleeding on palpation and incision margins on a five-point scale: 1 is very poor, 2 is poor, 3 is good, 4 is very good, and 5 is excellent
|
Baseline and 7 days, at 14 days, at 21 days, at 1 month and 3 months of follow-up
|
|
Radiographic image (x-ray)
Tidsramme: Baseline and 3 months follow-up
|
Periapical radiographs were taken using the parallel long cone technique using a customized film-holder device and a bite block.
- Bone level (BL): distance (mm) between the implant shoulder and the base of the defect.
|
Baseline and 3 months follow-up
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Publikationer og nyttige links
Generelle publikationer
- Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, Mealey BL, Papapanou PN, Sanz M, Tonetti MS. A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018 Jun;45 Suppl 20:S1-S8. doi: 10.1111/jcpe.12935.
- Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71. doi: 10.1111/jcpe.12334.
- Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, Chen S, Cochran D, Derks J, Figuero E, Hammerle CHF, Heitz-Mayfield LJA, Huynh-Ba G, Iacono V, Koo KT, Lambert F, McCauley L, Quirynen M, Renvert S, Salvi GE, Schwarz F, Tarnow D, Tomasi C, Wang HL, Zitzmann N. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1:S313-S318. doi: 10.1002/JPER.17-0739.
- Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Periodontol. 2018 Jun;89 Suppl 1:S267-S290. doi: 10.1002/JPER.16-0350.
- Herrera D, Berglundh T, Schwarz F, Chapple I, Jepsen S, Sculean A, Kebschull M, Papapanou PN, Tonetti MS, Sanz M; EFP workshop participants and methodological consultant. Prevention and treatment of peri-implant diseases-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2023 Jun;50 Suppl 26:4-76. doi: 10.1111/jcpe.13823. Epub 2023 Jun 4.
- Rokaya D, Srimaneepong V, Wisitrasameewon W, Humagain M, Thunyakitpisal P. Peri-implantitis Update: Risk Indicators, Diagnosis, and Treatment. Eur J Dent. 2020 Oct;14(4):672-682. doi: 10.1055/s-0040-1715779. Epub 2020 Sep 3.
- Robitaille N, Reed DN, Walters JD, Kumar PS. Periodontal and peri-implant diseases: identical or fraternal infections? Mol Oral Microbiol. 2016 Aug;31(4):285-301. doi: 10.1111/omi.12124. Epub 2015 Sep 15.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 250423_H42_general
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Peri-implantitis
-
Istanbul Medipol University HospitalAnkara University; Ankara Medipol University; Lokman Hekim UniversityAfsluttetPeri implantitis | Peri-implantat sundhed | Peri implantat mucositisTyrkiet (Türkiye)
-
Center of Implantology, Oral and Maxillofacial...RekrutteringPeri-implantitis og peri-implantat mucositisSpanien
-
King Abdullah University HospitalJordan University of Science and TechnologyAfsluttetPeri-implantitis og peri-implantat mucositisJordan
-
Recep Tayyip Erdogan UniversityIkke rekrutterer endnuPeri implantitis | Peri implantat mucositis
-
King's College LondonIkke rekrutterer endnu
-
University of MichiganOsteology FoundationRekrutteringPeri implantitisForenede Stater
-
Egas Moniz - Cooperativa de Ensino Superior, CRLRekrutteringPeri implantitisPortugal
-
University of ManitobaUkendtPeri implantitisCanada
-
Abeer HakamIkke rekrutterer endnuPeri implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdAfsluttet